LMT
29
2
MTCH
53
3
TROW
54
6
MSFT
46
2
K
56
5
KMB
34
6
PWR
66
7
ETN
69
2
PDCO
41
3
MMM
30
2
MAS
59
3
GE
61
4
V
56
2
DD
64
9
LUV
40
2
MU
39
5
FLR
60
4
SLB
45
4
BAC
39
3
PPL
54
5
LMT
29
2
MTCH
53
3
TROW
54
6
MSFT
46
2
K
56
5
KMB
34
6
PWR
66
7
ETN
69
2
PDCO
41
3
MMM
30
2
MAS
59
3
GE
61
4
V
56
2
DD
64
9
LUV
40
2
MU
39
5
FLR
60
4
SLB
45
4
BAC
39
3
PPL
54
5
Financhill
Back

ACADIA Pharmaceuticals Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
53

ACAD
ACADIA Pharmaceuticals

Last Price:
15.79
Seasonality Move:
20.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

ACADIA Pharmaceuticals Price Quote

$15.79
+0.79 (+5.27%)
(Updated: November 6, 2024 at 5:55 PM ET)

ACADIA Pharmaceuticals Key Stats

Buy
53
ACADIA Pharmaceuticals (ACAD) is a Buy
Day range:
$14.41 - $15.03
52-week range:
$14.15 - $32.59
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.79
P/B ratio:
4.82%
Volume:
1.9M
Avg. volume:
1.3M
1-year change:
-37.68%
Market cap:
$2.5B
Revenue:
$726.4M
EPS:
$0.18

How Much Does ACADIA Pharmaceuticals Make?

Is ACADIA Pharmaceuticals Growing As A Company?

ACADIA Pharmaceuticals Stock Price Performance

What Is ACADIA Pharmaceuticals 52-Week High & Low?

ACADIA Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy ACADIA Pharmaceuticals?

Is ACADIA Pharmaceuticals Cash Flow Positive?

  • What Is ACAD Cash Flow From Operations?
    Cash flow from operations (TTM) is $80.5M
  • What Is ACADIA Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $22.8M
  • What Is ACADIA Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$36.5M

ACADIA Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    ACAD return on invested capital is 7.04%
  • What Is ACADIA Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 4.03%
  • What Is ACAD Return On Equity?
    ROE is a measure of profitability and is 7.04%

ACADIA Pharmaceuticals Earnings Date & Stock Price

ACADIA Pharmaceuticals Competitors

ACADIA Pharmaceuticals Dividend Yield

ACADIA Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 1900% 13.9%
Revenue: 46.44% 2.67%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 25.11
Upside from Last Price: 67.37%

Major Shareholders

  • How many ACAD shares are owned by institutional investors?
    230.8M ACAD shares are owned by institutional investors
  • How many ACAD shares are owned by insiders?
    1.1M ACAD shares are owned by insiders